ArticleJournal of clinical neurology (Seoul, Korea)2025
Segmentation of the Hyperdense Artery Sign on Noncontrast CT in Ischemic Stroke Using Artificial Intelligence.
Article in Journal of clinical neurology (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence That Changes Clinical Neurology Practice: Translating Algorithms Into Actionable Care.Journal of clinical neurology (Seoul, Korea) · 2026Review
- Multicenter Validation of Artificial Intelligence Predicting Anterior Circulation Large Vessel Occlusion Using Noncontrast Head CT.Stroke (Hoboken, N.J.) · 2025Article
- Automated detection of hyperdense artery sign on non-contrast CT for rapid identification of large vessel occlusion: a multicenter validation study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
background and purposeWe developed and validated an automated hyperdense artery sign (HAS) segmentation algorithm for the distal internal carotid artery and middle cerebral artery on noncontrast brain computed tomography (NCCT) using a multicenter dataset with independent annotation performed by two experts.
methodsFor training and external validation, we included patients with ischemic stroke who underwent concurrent NCCT and CT angiography between May 2011 and December 2022 at six hospitals and one hospital, respectively. For clinical validation, nonoverlapping patients admitted within 24 hours of onset were consecutively included between December 2020 and April 2023 from six hospitals. The model was trained using the 2D U-Net deep-learning architecture with manual annotation by two experts. We constructed models trained on datasets annotated individually by each expert, and an ensemble model using shuffled annotations by both experts. The performance of the models was compared using the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity.
resultsThis study included 673, 365, and 774 patients in the training/internal validation, external validation, and clinical validation datasets, respectively, who were aged 68.8±13.2, 67.8±13.4, and 68.8±13.6 years (mean±standard deviation) and comprised 55.0%, 59.5%, and 57.6% males. The ensemble model achieved higher AUROC and sensitivity than the models trained on annotations by a single expert in the external validation. For the clinical validation dataset, the ensemble model exhibited an AUROC of 0.846 (95% confidence interval [CI], 0.819-0.871), sensitivity of 76.8% (95% CI, 65.1%-86.1%), and specificity of 88.5% (95% CI, 85.9%-90.8%). The predicted volume of the clot was correlated with the infarct volume in follow-up diffusion-weighted imaging (
conclusionsOur new algorithm can rapidly and accurately identify the HAS, and so can facilitate the screening of potential patients requiring intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.